Numerous pathologies associated with DS, including autoimmune-related disorders, are considered direct consequences of chronic IFN pathway activation (Madan et al., 2006; Mårild et al., 2013; Araya et al., 2019; Waugh et al., 2019; Bush et al., 2021). This evidence concerns the gene IFNA1 and Dravet syndrome.